pyridostigmine bromide has been researched along with Colitis, Ulcerative in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, H; Banerjee, S; Chand, HS; Raizada, V; Roy, S; Singh, SP; Sopori, M | 1 |
| Pai, YC; Yu, LC | 1 |
2 other study(ies) available for pyridostigmine bromide and Colitis, Ulcerative
| Article | Year |
|---|---|
Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis.
Topics: Acetylcholinesterase; Animals; Anti-Inflammatory Agents; Cholinesterase Inhibitors; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; GPI-Linked Proteins; Inflammation Mediators; Mucin-2; Pyridostigmine Bromide; Th2 Cells | 2020 |
Is "Cholinergic" Stimulus Useful for Ulcerative Colitis Treatment?
Topics: Acetylcholinesterase; Animals; Colitis, Ulcerative; Disease Models, Animal; Dysbiosis; Gastrointestinal Microbiome; Mice; Pyridostigmine Bromide | 2020 |